Efficacy News and Research

RSS
The ‘decade of vaccines’ has the potential to save lives, many challenges ahead

The ‘decade of vaccines’ has the potential to save lives, many challenges ahead

Abbott reports positive interim results from LCIG Phase III open-label study for advanced Parkinson's disease

Abbott reports positive interim results from LCIG Phase III open-label study for advanced Parkinson's disease

ImmunoCellular expands ICT-107 Phase II clinical trial for glioblastoma multiforme

ImmunoCellular expands ICT-107 Phase II clinical trial for glioblastoma multiforme

Patient enrollment complete in cilengitide Phase III study against glioblastoma

Patient enrollment complete in cilengitide Phase III study against glioblastoma

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Therapeutic equivalent to replace penicillin

Therapeutic equivalent to replace penicillin

Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO

Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO

NYU Cancer Institute scientists present new research findings at ASCO 2011

NYU Cancer Institute scientists present new research findings at ASCO 2011

New palonosetron-aprepitant trial data on chemotherapy induced nausea, vomiting presented at EHA

New palonosetron-aprepitant trial data on chemotherapy induced nausea, vomiting presented at EHA

Millennium reports results from two VELCADE based combination studies against multiple myeloma

Millennium reports results from two VELCADE based combination studies against multiple myeloma

Vaccine candidate produces immune response to antigen in all strains of influenza A

Vaccine candidate produces immune response to antigen in all strains of influenza A

OzHealth Pharma, Moberg Derma partner to distribute Emtrix in Australia and New Zealand

OzHealth Pharma, Moberg Derma partner to distribute Emtrix in Australia and New Zealand

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

New Westchester Montefiore Laser and Eye Center to offer ophthalmology services

New Westchester Montefiore Laser and Eye Center to offer ophthalmology services

FDA grants orphan drug designation for Edison's EPI-743 to treat inherited mitochondrial diseases

FDA grants orphan drug designation for Edison's EPI-743 to treat inherited mitochondrial diseases

Top-line results from Cipher's CIP-ISOTRETINOIN Phase III study against severe nodular acne

Top-line results from Cipher's CIP-ISOTRETINOIN Phase III study against severe nodular acne

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

FDA accepts Topaz's ivermectin NDA for treatment for head lice infestations

FDA accepts Topaz's ivermectin NDA for treatment for head lice infestations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.